Christopher Kuebler Net Worth & Insider Trades
Christopher Kuebler - Director, Nektar Therapeutics
What is Christopher Kuebler's Net Worth?
The current estimated net worth of Nektar Therapeutics's Director, Christopher Kuebler, is estimated to be about $19.39M . Christopher Kuebler owns about 40,500 units of Nektar Therapeutics common stock. In the last 15 years at Nektar Therapeutics, Christopher Kuebler has sold an estimated value of $6.99M worth.
What is Christopher Kuebler's Past Insider Trading?
Christopher Kuebler's largest purchase order was 30,000 units , worth over $427.8K on January 4, 2018. Christopher Kuebler's largest sale order was 40,000 units , worth over $3.9M on March 8, 2018. In total, Christopher Kuebler has made about 29 transactions over 15 years of their time at Nektar Therapeutics. Christopher Kuebler usually trades in September, with the busiest year in 2018, 2015 and 2017.
CHRISTOPHER KUEBLER
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Christopher Kuebler's' Mailing Address?
- Mailing address is 210 Carnegie Center Princeton NJ 08540 NJ
What are Nektar Therapeutics's Past Insider Trades?
Nektar Therapeutics's most recent insider trade came on February 17, 2023 by Jonathan Zalevsky who sold 10,484 units worth $31.45K . In the last 20 years, insiders at Nektar Therapeutics have sold an estimated value of $295.28M and bought an estimated value of $84.98M worth of shares. Insider trading is most common in September, with the busiest year in 2017 and 2016. The most active traders at the company are Gil Labrucherie, SVP, Howard Robin, President & CEO, and Robert Chess, Director .
NEKTAR THERAPEUTICS Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||